ICN Pharmaceuticals Inc said board approved purchase three mln share outstanding common stock .
ICN also said plan buy 500,000 share Viratek Inc & lt ; VIRA > SPI Pharmaceuticals Inc & lt ; SPIP > .
ICN said buyback plan approved board believed current price investment represented ICN group best interest shareholder company .
Reuter & # 3 ; 